Has advised
Eiger BioPharmaceuticals, Inc.
in the sale to
Sentynl Therapeutics, Inc.
M&A Sell-Side
$20-50M
2024
United States
Healthcare and Pharmaceutical
Some other Transactions by the Firm
Interested in becoming a member of GCG?
If you are an international M&A advisory firm and you are regarded as one of the leading firms in your profession in your country, consistently providing excellent client services and meeting high quality standards, you meet the basic requirements for a GCG membership.